제12차 대한종양내과학회 학술대회 및 2019 국제학술대회 : 2019-11-07
교육일자 : 2019-11-07
교육장소 : 드래곤씨티 한라룸 외  
교육주제 : 제12차 대한종양내과학회 학술대회 및 2019 국제학술대회
주최기관 : 대한종양내과학회(17.5 명칭변경 한국임상암학회)
담당자 : 강해진
연락처 : 02-735-2857  
이메일 : ksmo3@ksmo.or.kr      
교육종류 : 내과, 방사선종양학과, 병리과의료정책
참석예상인원 : 1000명
희망평점 : 6점  
지역 : 서울특별시
교육시간 : 28 시간 40분  
세부수강료 : 170,000원      
비고 교수/전문의/전임의(학교및병원) - 회원 사전 100,000원 현장 120,000원 교수/전문의/전임의(학교및병원) - 비회원 사전 120,000원 현장 150,000원 전공의/간호사/약사/군의관/학생 - 회원 사전 50,000원 현장 70,000원 전공의/간호사/약사/군의관/학생 -비회원 사전 70,000원 현장 90,000원 기업/기타 - 회원 사전 100,000 현장 120,000원 기업/기타 - 비회원 사전 140,000 현장 170,000원      

구분 월일 강의실 시간 교육제목  강사명(소속) 필수과목
교육시간 11-07 HALLA 1&2 09:00~09:25 Precision medicine in NSCLC: Current interpretation of biomarkers from NGS  Myung-Ju AHN(Samsung Medical Center Korea) 
교육시간 11-07 HALLA 1&2 09:25~09:50 Precision medicine in advanced prostate cancer  Emmanuel S. ANTONARAKIS(The Johns Hopkins University USA) 
교육시간 11-07 HALLA 1&2 09:50~10:15 Gastric cancer in the era of precision medicine  Jeeyun LEE(Samsung Medical Center Korea) 
교육시간 11-07 HALLA 3 09:00~09:18 AI, big data and oncology  Yoon Sup CHOI(DHP Korea) 
교육시간 11-07 HALLA 3 09:18~09:36 Artificial intelligence for lung cancer imaging  Kyu-Hwan JUNG(Vuno Korea) 
교육시간 11-07 HALLA 3 09:36~09:54 AI technologies for diagnosis of rare genetic cancer  Changwon KEUM(3 Billion Korea) 
교육시간 11-07 HALLA 3 09:54~10:15 Deep learning for cancer precision medicine  Seong Eui HONG(Theragen Korea) 
교육시간 11-07 BAEKDU 1&2 09:00~09:25 Promises and challenges of immunotherapy  Aung NAING(MD Anderson Cancer Center USA) 
교육시간 11-07 BAEKDU 1&2 09:25~09:50 Emerging immuno-oncology targets and combination therapies  Cathy PIETANZA(MSD USA) 
교육시간 11-07 BAEKDU 1&2 09:50~10:15 CAR-T therapy for solid tumors  Edmund K MOON(Hospital of the University of Pennsylvania USA) 
교육시간 11-07 BAEKDU 3 09:00~09:25 Targeted therapy and biomarkers in hepatocellular carcinoma  Changhoon YOO(Asan Medical Center Korea) 
교육시간 11-07 BAEKDU 3 09:25~09:50 Immunotherapy and biomarkers in hepatocellular carcinoma  Hong Jae CHON(CHA Bundang Medical Center Korea) 
교육시간 11-07 BAEKDU 3 09:50~10:15 Future of clinical trials in hepatocellular carcinoma  Stephen L. CHAN(The Chinese University of Hong Kong Hong Kong) 
교육시간 11-07 HALLA 1&2 10:30~11:10 Targeting DNA repair in Breast Cancer  Andrew TUTT(The Institute of Cancer Research UK) 
교육시간 11-07 HALLA 1&2 11:10~11:50 The VHL tumor suppressor gene: Insights into oxygen sensing and cancer  William G. KAELIN Jr.(Dana-Farber Cancer Institute USA) 
교육시간 11-07 HALLA 1&2 11:50~12:30 New Horizon of Neoadjuvant and Adjuvant Treatment in HER2-positive Breast Cancer  Yeon Hee PARK(Samsung Medical Center Korea) 
교육시간 11-07 BAEKDU 1&2 11:50~12:30 New perspectives for the future treatment option in non small cell lung cancer  Natasha B. LEIGHL(Princess Margaret Cancer Centre Canada) 
휴식 11-07  12:30~12:50 Break  () 
교육시간 11-07 HALLA 1&2 12:50~13:20 How to accept my manuscript to the high impact journal?  Alex A. ADJEI(Mayo Clinic USA) 
교육시간 11-07 HALLA 1&2 13:20~13:50 Doing great research and writing great papers in high impact journals  Jeong Ho LEE(KAIST Korea) 
교육시간 11-07 BAEKDU 1&2 12:50~13:10 Immune checkpoint inhibitors  Jung Ae SEO(National Cancer Center Korea) 
교육시간 11-07 BAEKDU 1&2 13:10~13:30 Identification and management of toxicities related to immuno-oncologic therapy  Juhyang CHEON(Yeungnam University Hospital Korea) 
교육시간 11-07 BAEKDU 1&2 13:30~13:50 Oncology pharmacist’s role in immuno-oncologic therapy  Soyeon HONG(Seoul National University Bundang Hospital Korea) 
교육시간 11-07 HALLA 3 14:10~14:40 STING signaling regulates immune-vascular crosstalk to enhance anti-tumor immunity  Chan KIM(CHA Bundang Medical Center Korea) 
교육시간 11-07 HALLA 3 14:40~15:10 Immune surveillance and the role of the endogenous angiogenesis inhibitors thrombospondin-1 and endostatin in tumor immunity  Sandra RYEOM(UPENN USA) 
교육시간 11-07 HALLA 3 15:10~15:40 Leverages advanced technologies to investigate microbiomes and their clinical impact  Julia OH(The Jackson Laboratory USA) 
교육시간 11-07 HALLA 1&2 14:10~14:35 Precision genomics-based patients’ care - ASCO’s TAPUR study  Edward Sanghyun KIM(Levine Cancer Institute USA) 
교육시간 11-07 HALLA 1&2 14:35~15:00 Clinical applications of NGS in Korea  Tae-You KIM(Seoul National University Hospital Korea) 
교육시간 11-07 HALLA 1&2 15:00~15:25 Global collaboration in genomic data sharing and use  Subha MADHAVAN(Georgetown University USA) 
토론 11-07 HALLA 1&2 15:25~15:40 Q&A  () 
교육시간 11-07 BAEKDU 1&2 14:10~14:40 Radiotherapy and Immunotherapy - New strategy for better outcome  Adam RABEN(Christiana Care Health System USA) 
교육시간 11-07 BAEKDU 1&2 14:40~15:05 Radiotherapy and Immunotherapy - On ongoing clinical trial  Jin Ho KIM(Seoul National University Hospital Korea) 
교육시간 11-07 BAEKDU 1&2 15:05~15:30 Toxicities of the combination of radiotherapy and immunotherapy  Keun-Wook LEE(Seoul National University Bundang Hospital Korea) 
토론 11-07 BAEKDU 1&2 15:30~15:40 Q&A  () 
교육시간 11-07 BAEKDU 3 14:10~14:32 Principles of clinical advances of molecular targeted agent  Moon Ki CHOI(National Cancer Center Korea) 
교육시간 11-07 BAEKDU 3 14:32~14:55 Principles of clinical advances of I-O  Eun Joo KANG(Korea University Guro Hospital Korea) 
교육시간 11-07 BAEKDU 3 14:55~15:17 Management of molecular targeted agent-related AEs  Gyeong-Won LEE(Gyeongsang National University Hospital Korea) 
교육시간 11-07 BAEKDU 3 15:17~15:40 Management of immune-related AEs  Yun-Gyoo LEE(Kangbuk Samsung Hospital Korea) 
교육시간 11-07 HALLA 3 16:00~16:30 Development of CDK4/6 inhibitor for solid tumor  Richard FINN(UCLA USA) 
교육시간 11-07 HALLA 3 16:30~17:00 Genetic landscape of hepatitis B virus–associated diffuse large B-cell lymphoma: Insights for novel targeted therapies  Qiang PAN-HAMMARSTRÖM(Karolinska Institutet Sweden) 
교육시간 11-07 HALLA 3 17:00~17:30 Genomic Predictors of Disease Progression in Gastrointestinal Cancer  Patrick TAN(Duke-NUS Medical School Singapore) 
교육시간 11-07 BAEKDU 1&2 16:00~16:20 The role of PARPi in ovarian cancer  Keun Ho LEE(Seoul St. Mary’s Hospital Korea) 
교육시간 11-07 BAEKDU 1&2 16:20~16:40 IO for ovarian cancer  Gun Min KIM(Yonsei Cancer Center Korea) 
교육시간 11-07 BAEKDU 1&2 16:40~17:00 Combination of PARP inhibitors and Immune checkpoint inhibitors in ovarian cancer  Jung-Min LEE(National Cancer Institute USA) 
교육시간 11-07 BAEKDU 1&2 17:00~17:20 International collaboration in GY cancer clinical research  Elise C. KOHN(National Cancer Institute USA) 
토론 11-07 BAEKDU 1&2 17:20~17:30 Q&A  () 
교육시간 11-07 HALLA 1&2 16:00~16:25 Integrated precision medicine platform for data-sharing in USA  Peter Goodhand(Global Alliance for Genomics and Health Canada) 
교육시간 11-07 HALLA 1&2 16:25~16:50 How can we incorporate NGS data-sharing platform for precision medicine in Korea?  Woong Yang PARK(Samsung Medical Center Korea) 
교육시간 11-07 HALLA 1&2 16:50~17:15 KSMO-KCSG Korean precision medicine networking group initiative* KSMO: Korean Society of Medical Oncology, KCSG: Korean Cancer Study Group  Jee Hyun KIM(Seoul National University Bundang Hospital Korea) 
토론 11-07 HALLA 1&2 17:15~17:30 Q&A  () 
교육시간 11-07 BAEKDU 3 16:00~16:05 오프닝 및 연자소개  Bong-Seog KIM(vhs medical center Korea) 
교육시간 11-07 BAEKDU 3 16:05~16:25 국내 상황 설명  Dae Ho LEE(Asan Medical Center Korea) 
교육시간 11-07 BAEKDU 3 16:25~17:10 영국 사례 소개  TBD() 
교육시간 11-07 BAEKDU 3 17:10~17:55 미국 사례 소개  CMS(Center for Medicare and Medicaid Services (CMS) USA) 
토론 11-07 BAEKDU 3 17:55~18:30 패널 토의  연사 모두() 
교육시간 11-07 HALLA 1 17:30~18:00 Recent clinical trials in adjuvant therapy for resected pancreatic cancer  Dong-Hoe KOO(Kangbuk Samsung Hospital Korea) 
교육시간 11-07 HALLA 1 18:00~18:30 FOLFIRINOX in localized pancreatic cancer: It  Changhoon YOO(Asan Medical Center Korea) 
교육시간 11-07 HALLA 2 17:30~17:50 From clinical trials to practice: CDK4/6 inhibitors for HR+ HER2- mBC treatment  Richard FINN(UCLA USA) 
교육시간 11-07 HALLA 2 17:50~18:10 CDK4/6 inhibitors in future directions: understanding resistance & next sequence of therapies  Kyong Hwa PARK(Korea University Anam Hospital Korea) 
교육시간 11-07 HALLA 2 18:10~18:30 Current unmet needs in TNBC and and evolving therapeutic strategies  Andrew TUTT(The Institute of Cancer Research UK) 
교육시간 11-07 HALLA 3 17:30~18:00 Targeting BRAF V600E NSCLC  Se Hoon LEE(Samsung Medical Center Korea) 
교육시간 11-07 HALLA 3 18:00~18:30 Optimizing treatment of neuroendocrine tumor in lung  Shin-kyo YOON(Asan Medical Center Korea) 
교육시간 11-07 BAEKDU 1 17:30~18:00 Clinical benefit of ramucirumab as second-line therapy in advanced gastric cancer  Minkyu JUNG(Yonsei Cancer Center Korea) 
교육시간 11-07 BAEKDU 1 18:00~18:30 Role of Anti-angiogenic agents in mCRC and Clinical practice in Japan  Akitaka MAKIYAMA(Japan Community Healthcare Organization Kyushu Hospital Japan) 
교육시간 11-07 BAEKDU 2 17:30~17:50 Assessment, management, and barriers of breakthrough cancer pain: a nationwide study in Korea  Su-Jin KOH(Ulsan University Hospital Korea) 
교육시간 11-07 BAEKDU 2 17:50~18:10 Individualized Treatment Strategies for Breakthrough Cancer Pain  Seonghoon SHIN(Kosin University Gospel Hospital Korea) 
교육시간 11-07 BAEKDU 2 18:10~18:30 BTcP management; real world practice (including Abstral case review)  David Hui(The University of Texas MD Anderson Cancer Center USA) 
교육시간 11-07 BAEKJE 17:30~18:00 Elevating the Treatment Paradigm with Nivolumab in NSCLC  Young Joo MIN(Ulsan University Hospital Korea) 
교육시간 11-07 BAEKJE 18:00~18:30 Rethinking the management of Advanced RCC in an Evolving Therapeutic Landscape  Chan KIM(CHA Bundang Medical Center Korea)